Comparison of two ELISA assays for anti-Sp100 determination

Annals of the New York Academy of Sciences

Volumn 1109, Issue , 2007, Pages 203-211

  Lucena, José Manuel ^a   Cano, Marcos Montes ^a   Caro, José Luis ^a   Respaldiza, Nieves ^a   Alvarez, Antonia ^a   Sánchez Román, Julio ^a   Núñez Roldán, Antonio ^a   Wichmann, Ingeborg ^a  

^a HOSPITAL UNIVERSITARIO VIRGEN DEL ROCÍO   (Spain)

Author keywords

AMA; ELISA assay; Multiple nuclear dots; PBC; Sp100

Indexed keywords

EPITOPE; MITOCHONDRION ANTIBODY; ANTIBODY; AUTOANTIGEN; CELL NUCLEUS ANTIGEN; NUCLEAR PROTEIN; SP100 PROTEIN, HUMAN; UNCLASSIFIED DRUG;

ANTIGEN SPECIFICITY; BONE DISEASE; CONFERENCE PAPER; CONNECTIVE TISSUE DISEASE; CONTROLLED STUDY; CORRELATION ANALYSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; HEMATOLOGIC DISEASE; HUMAN; HUMAN CELL; LIVER DISEASE; LUNG DISEASE; MAJOR CLINICAL STUDY; PRIMARY BILIARY CIRRHOSIS; SYSTEMIC LUPUS ERYTHEMATOSUS; ARTICLE; BLOOD; COMPARATIVE STUDY; IMMUNOLOGY; METHODOLOGY; MITOCHONDRION; TUMOR CELL LINE;

ANTIBODIES; ANTIGENS, NUCLEAR; AUTOANTIGENS; CELL LINE, TUMOR; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; MITOCHONDRIA; NUCLEAR PROTEINS;

EID: 34848888965     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1196/annals.1398.024     Document Type: Conference Paper

References (31)

1. HARADA, K. et al. 1999. In situ nucleic acid detection of PDC-E2, BCOADC-E2, OGDC-E2, PDC-E1alpha, BCOADC-E1alpha, OGDC-E1, and the E3 binding protein (protein X) in primary biliary cirrhosis. Hepatology 30: 36-45.
2. COURVALIN, J.C. et al. 1990. The 210-kD nuclear envelope polypeptide recognized by human autoantibodies in primary biliary cirrhosis is the major glycoprotein of the nuclear pore. J. Clin. Invest. 86: 270-285.
3. HANSEN, B.U. et al. 1991. High prevalence of autoimmune liver disease in patients with multiple nuclear dot, anti-centromere, and mitotic spindle antibodies. Scand. J. Gastroenterol. 26: 707-713.
4. PAWLOTSKY, J.M. et al. 1992. Multiple nuclear dots antinuclear antibodies are not specific for primary biliary cirrhosis. Hepatology 16: 127-131.
5. WICHMANN, I. et al. 2003. Clinical significance of anti-multiple nuclear dots/Sp100 autoantibodies. Scand. J. Gastroenterol. 38: 996-999.
6. ZÜCHNER, D. et al. 1997. Prevalence, kinetics, and therapeutic modulation of autoantibodies against Sp100 and promyelocytic leukemia protein in a large cohort of patients with primary biliary cirrhosis. Hepatology 26: 1123-1130.
7. SZOSTECKI, C. et al. 1992. Autoantibodies to the nuclear Sp100 protein in primary biliary cirrhosis and associated diseases: epitope specificity and immunoglobulin class distribution. Scand. J. Immunol. 36: 555-564.
8. RIGOPOULOU, E.I. et al. 2005. Prevalence and clinical significance of isotype specific antinuclear antibodies in primary biliary cirrhosis. Gut 54: 528-532.
9. WEIS, K. et al. 1994. Retinoic acid regulates aberrant nuclear localization of PML-RAR alpha in acute promyelocytic leukemia cells. Cell 76: 345-356.
10. LEHMING, N. et al. 1998. Chromatin components as part of a putative transcriptional repressing complex. Proc. Natl. Acad. Sci. USA 95: 7322-7326.
11. GULDNER, H.H. et al. 1992. IFN enhance expression of Sp100, an autoantigen in primary biliary cirrhosis. J. Immunol. 149: 4067-4073.
12. STERNSDORF, T. et al. 1995. Two nuclear dot-associated proteins, PML and Sp100, are often co-autoimmunogenic in patients with primary biliary cirrhosis. Scand. J. Immunol. 42: 257-268.
13. JANKA, C. et al. 2005. Small ubiquitin-related modifiers: a novel and independent class of antigens in primary biliary cirrhosis. Hepatology 41: 609-616.
14. SZOSTECKI, C. et al. 1990. Isolation and characterization of cDNA encoding a human nuclear antigen predominantly recognized by autoantibodies from patients with primary biliary cirrhosis. J. Immunol. 145: 4338-4347.
15. GULDNER, H.H. et al. 1999. Splice variants of the nuclear dot-associated Sp100 protein contain homologies to HMG-1 and a human nuclear phosphoprotein-box motif. J. Cell Sci. 112: 733-747.
16. GRÖTZINGER, T. et al. 1996. Interferon-modulated expression of genes encoding the nuclear-dot-associated proteins Sp100 and promyelocytic leukemia protein (PML). Eur. J. Biochem. 238: 554-560.
17. NEGOREV, D.G. et al. 2006. Differential role of Sp100 isoforms in interferon-mediated repression of herpes simplex virus type 1 immediate-early protein expression. J. Virol. 80: 8019-8029.
18. WILCOX, K.W. et al. 2005. SP100B is a repressor of gene expression. J. Cell Biochem. 95: 352-365.
19. TAAL, B.G. et al. 1983. Clinical diagnosis of primary biliary cirrhosis: a classification based on major and minor criteria. Hepatogastroenterology 30: 178-182.
20. BLUTHNER, M. et al. 1999. Identification of major linear epitopes on the sp100 nuclear PBC autoantigen by the gene-fragment phage-display technology. Autoimmunity 29: 33-42.
21. SEELER, J.S. et al. 1998. Interaction of SP100 with HP1 proteins: a link between the promyelocytic leukemia-associated nuclear bodies and the chromatin compartment. Proc. Natl. Acad. Sci. USA 95: 7316-7321.
22. STERNSDORF, T. et al. 1999. The nuclear dot protein sp100, characterization of domains necessary for dimerization, subcellular localization, and modification by small ubiquitin-like modifiers. J. Biol. Chem. 274: 12555-12566.
23. VAN DE WATER, J. et al. 2001. Molecular mimicry and primary biliary cirrhosis: premises not promises. Hepatology 33: 771-775.
24. ANAND, A.C. et al. 1996. End-stage primary biliary cirrhosis in a first generation migrant south Asian population. Eur. J. Gastroenterol. Hepatol. 8: 663-666.
25. BOGDANOS, D.P. et al. Association between the primary biliary cirrhosis specific anti-sp100 antibodies and recurrent urinary tract infection. Dig. Liver Dis. 35: 801-805.
26. BOGDANOS, D.P. et al. 2002. Antibodies against homologous microbial caseinolytic proteases P characterise primary biliary cirrhosis. J. Hepatol. 36: 24-21.
27. MAYO, I. et al. 2000. Antibodies against the COOH-terminal region of E. coli ClpP protease in patients with primary biliary cirrhosis. J. Hepatol. 33: 528-536.
28. LUETTIG, B. et al. 1998. The antinuclear autoantibodies Sp100 and gp210 persist after orthotopic liver transplantation in patients with primary biliary cirrhosis. J. Hepatol. 28: 824-828.
29. HAYDON, H.G. & J. NEUBERGER. 2000. PBC: an infectious disease? Gut 47: 586-588.
30. SHIMODA, S. et al. 2003. Molecular mimicry of mitochondrial and nuclear autoantigens in primary biliary cirrhosis. Gastroenterology 124: 1915-1925.
31. XIE, K. & M. ZINDER. 1995. Two short autoepitopes on the nuclear dot antigen are similar to epitopes encoded by the Epstein-Barr virus. Proc. Natl. Acad. Sci. USA 92: 1639-1643.